Cargando…
Immune-Related Adverse Events of the Gastrointestinal System
SIMPLE SUMMARY: Immunotherapy is an effective cancer treatment that activates the immune system to target and destroy cancer cells. The emerging use of a form of immunotherapy referred to as immune checkpoint inhibitors is often limited by the development of immune-related adverse events. This often...
Autores principales: | Nicolaides, Steven, Boussioutas, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913287/ https://www.ncbi.nlm.nih.gov/pubmed/36765649 http://dx.doi.org/10.3390/cancers15030691 |
Ejemplares similares
-
Gastrointestinal disorders as immune-related adverse events
por: Balducci, Daniele, et al.
Publicado: (2021) -
Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
por: Rajha, Eva, et al.
Publicado: (2019) -
Gastrointestinal adverse events of immunotherapy
por: Cappello, Giovanni, et al.
Publicado: (2021) -
Immune checkpoint inhibitor-associated gastrointestinal and hepatic
adverse events and their management
por: Shivaji, Uday N., et al.
Publicado: (2019) -
Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Bai, Xiaoyin, et al.
Publicado: (2021)